Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from SPMSD (reference number E2014-01700) on 27-FEB-2014. Case was received from a health care professional via the Health Authorities on 25-Feb-2014 under the references DK-DKMA-ADR 22430204 and DK-DKMA-EFO8281. Case is medically confirmed. Primary source was a physician. A 13-year-old female patient (weight 56 kg, height 177 cm) with a medical history of positive Epstein-Barr virus test, cytomegalovirus test and human Herpes virus 6 test as well as celiac disease received an injection of GARDASIL, (batch number NN02290, lot # NK44350, expiration date 31-MAY-2012) intramuscular route into not reported site of administration on 30-Aug-2011. On 01-Sep-2011, the patient developed postural orthostatic tachycardia syndrome. On an unspecified date, the patient also developed orthostatic discomfort, heart palpitation, shortness of breath on physical exertion, chest pain on physical exertion, headache, frequent urination and muscle cramps. Tilt table test showed significant increase of heart rate ($g40 bpm) and tendency to decrease in blood pressure. The patient was also investigated for infectious diseases revealing positive tests for EBV, CMV and HH6. It was unknown if other vaccines or medicines were given. At the time of reporting, the patient had not recovered.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166